Occupational Exposure to Pesticides Affects Pivotal Immunologic Anti-Tumor Responses in Breast Cancer Women from the Intermediate Risk of Recurrence and Death
- PMID: 36358618
- PMCID: PMC9655347
- DOI: 10.3390/cancers14215199
Occupational Exposure to Pesticides Affects Pivotal Immunologic Anti-Tumor Responses in Breast Cancer Women from the Intermediate Risk of Recurrence and Death
Abstract
Breast cancer risk stratification is a strategy based using on clinical parameters to predict patients' risk of recurrence or death, categorized as low, intermediate, or high risk. Both low and high risk are based on well-defined clinical parameters. However, the intermediate risk depends on more malleable parameters. It means an increased possibility for either suboptimal treatment, leading to disease recurrence, or systemic damage due to drug overload toxicity. Therefore, identifying new factors that help to characterize better the intermediate-risk stratification, such as environmental exposures, is necessary. For this purpose, we evaluated the impact of occupational exposure to pesticides on the systemic profile of cytokines (IL-12, IL-4, IL-17A, and TNF-α) and oxidative stress (hydroperoxides, total antioxidants, and nitric oxide metabolites), as well as TGF-β1, CTLA-4, CD8, and CD4 expression, investigated in tumor cells. Occupational exposure to pesticides decreased the levels of IL-12 and significantly increased the expression of TGF-β1 and CTLA-4 in the immune infiltrate. Nevertheless, we observed a decrease in CTLA-4 in tumor samples and CD8 in infiltrating cells of intermediate overweight or obese patients with at least one metastatic lymph node at the diagnosis. These findings indicate that occupational exposure to pesticides changes the molecular behavior of disease and should be considered for intermediate-risk stratification assessment in breast cancer patients.
Keywords: breast cancer; cytokine; inflammation; oxidative stress; pesticide exposure; risk stratification.
Conflict of interest statement
The authors declare no conflict of interest.
Figures






Similar articles
-
Occupational exposure to pesticides deregulates systemic cortisol levels in women with breast cancer and correlates with poor prognosis features.Braz J Med Biol Res. 2024 Jan 22;57:e13060. doi: 10.1590/1414-431X2023e13060. eCollection 2024. Braz J Med Biol Res. 2024. PMID: 38265341 Free PMC article.
-
Occupational exposure to pesticides dysregulates systemic Th1/Th2/Th17 cytokines and correlates with poor clinical outcomes in breast cancer patients.Front Immunol. 2023 Oct 24;14:1281056. doi: 10.3389/fimmu.2023.1281056. eCollection 2023. Front Immunol. 2023. PMID: 37942322 Free PMC article.
-
Occupational exposure to pesticides affects systemic cytokine profile and correlates with poor clinical prognosis in young women with breast cancer.Immunopharmacol Immunotoxicol. 2025 Feb;47(1):34-41. doi: 10.1080/08923973.2024.2430665. Epub 2024 Dec 1. Immunopharmacol Immunotoxicol. 2025. PMID: 39587784
-
Overview of resistance to systemic therapy in patients with breast cancer.Adv Exp Med Biol. 2007;608:1-22. doi: 10.1007/978-0-387-74039-3_1. Adv Exp Med Biol. 2007. PMID: 17993229 Review.
-
Cooperation of liver cells in health and disease.Adv Anat Embryol Cell Biol. 2001;161:III-XIII, 1-151. doi: 10.1007/978-3-642-56553-3. Adv Anat Embryol Cell Biol. 2001. PMID: 11729749 Review.
Cited by
-
Occupational exposure to pesticides deregulates systemic cortisol levels in women with breast cancer and correlates with poor prognosis features.Braz J Med Biol Res. 2024 Jan 22;57:e13060. doi: 10.1590/1414-431X2023e13060. eCollection 2024. Braz J Med Biol Res. 2024. PMID: 38265341 Free PMC article.
-
Molecular and serological biomarkers to predict trastuzumab responsiveness in HER-2 positive breast cancer.J Med Life. 2023 Nov;16(11):1633-1638. doi: 10.25122/jml-2023-0163. J Med Life. 2023. PMID: 38406785 Free PMC article.
-
Brief research report pesticide occupational exposure leads to significant inflammatory changes in normal mammary breast tissue.Front Public Health. 2023 Sep 14;11:1229422. doi: 10.3389/fpubh.2023.1229422. eCollection 2023. Front Public Health. 2023. PMID: 37780419 Free PMC article.
-
From lab to life: technological innovations in transforming cancer metastasis detection and therapy.Discov Oncol. 2025 Aug 10;16(1):1517. doi: 10.1007/s12672-025-02910-8. Discov Oncol. 2025. PMID: 40783899 Free PMC article. Review.
-
Occupational exposure to pesticides dysregulates systemic Th1/Th2/Th17 cytokines and correlates with poor clinical outcomes in breast cancer patients.Front Immunol. 2023 Oct 24;14:1281056. doi: 10.3389/fimmu.2023.1281056. eCollection 2023. Front Immunol. 2023. PMID: 37942322 Free PMC article.
References
-
- Sparano J.A., Gray R.J., Ravdin P.M., Makower D.F., Pritchard K.I., Albain K.S., Hayes D.F., Geyer C.E., Dees E.C., Goetz M.P., et al. Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer. N. Engl. J. Med. 2019;380:2395–2405. doi: 10.1056/NEJMoa1904819. - DOI - PMC - PubMed
-
- Goldhirsch A., Wood W.C., Coates A.S., Gelber R.D., Thürlimann B., Senn H.-J., Panel members Strategies for subtypes—Dealing with the diversity of breast cancer: Highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann. Oncol. 2011;22:1736–1747. doi: 10.1093/annonc/mdr304. - DOI - PMC - PubMed
-
- SBOC Guideline 2011. Rev. Soc Bras. Oncol. Clín. 2011;589
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials